In the initial evaluation of patients with dementia, the American Academy of Neurology recommends structural neuroimaging with either a noncontrast CT scan or MRI. This is primarily to identify any lesions that may cause cognitive impairment and rule out potentially treatable causes of progressive cognitive decline, such as chronic subdural hematoma or normal-pressure hydrocephalus. Still, although brain MRIs or CT scans can show diffuse cortical and/or cerebral atrophy in patients with AD, these findings are not considered diagnostic.
Brain SPECT scan or PET scan are not recommended in the routine workup of patients with typical presentations of AD. However, they may be an appropriate approach in patients with atypical AD presentations or when a form of frontotemporal dementia is suspected.
Learn more about imaging in AD.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Jasvinder P. Chawla. Fast Five Quiz: Alzheimer's Disease Workup - Medscape - Feb 22, 2022.